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Abstract
Isolation of high quality cardiomyocytes is critically important for achieving successful
experiments in many cellular and molecular cardiology studies. Methods for isolating cardi-
omyocytes from the murine heart generally are time-sensitive and experience-dependent,
and often fail to produce high quality cells. Major technical difficulties can be related to the
surgical procedures needed to explant the heart and to cannulate the vessel to mount onto
the Langendorff system before in vitro reperfusion can begin. During this period, transient
hypoxia and ischemia may damage the heart, resulting in low yield and poor quality of cells,
especially for heart disease models that have fragile cells. We have developed novel in vivo
cannulation methods to minimize hypoxia and ischemia, and fine-tuned the entire protocol
to produce high quality ventricular myocytes. The high cell quality has been confirmed using
important structural and functional criteria such as morphology, t-tubule structure, action
potential morphology, Ca2+ signaling, responsiveness to beta-adrenergic agonist, and abil-
ity to have robust contraction under mechanically loaded condition. Together these assess-
ments show the preservation of the cardiac excitation–contraction machinery in cells
isolated using this technique. The in vivo cannulation method enables consistent isolation
of high-quality cardiomyocytes, even from heart disease models that were notoriously diffi-
cult for cell isolation using traditional methods.
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Introduction
Isolation of high quality cardiomyocytes is critically important for achieving successful and
reproducible experiments in cellular and molecular cardiology. However, a majority of the
methods used for isolating cardiomyocytes from murine hearts are known to be technically
challenging and often produce variable results, especially for some heart disease and transgenic
models that have particularly fragile cardiomyocytes. The traditional method of isolating cardi-
omyocytes uses a series of procedures that are critically time sensitive and highly dependent on
experience [1–6]. Generally in the traditional approach, the chest is opened which causes cessa-
tion of respiration and therefore subjects the heart and its cells to a hypoxic environment.
Next, the heart is excised; the blood is washed away, and the excess tissue removed to expose
the aorta. Subsequently, the small caliber aorta must be cannulated to allow its attachment to
the Langendorff system; and only then, can in vitro perfusion be started to reoxygenate the tis-
sue. These operations usually take a lengthy period of time during which transient hypoxia and
ischemia can damage the heart, resulting in a low yield and poor quality of cardiomyocytes.
Moreover, as a common practice butanedione monoxime (BDM) is often used to eliminate the
contraction of myofilaments during the procedure[7] in order to decrease reoxygenation injury
[8] and potentially protect hearts from ischemia–reperfusion injury[7–9]. However, BDM is a
non-specific phosphatase and can cause significant side effects on the cardiomyocytes includ-
ing a loss of excitability[3], altered electrical properties and abnormal Ca2+ handling[10–13].
Therefore it remains challenging to isolate high quality cardiomyocytes from murine hearts
that are free from artifacts associated with non-physiological cell isolation conditions.
Preservation of an adequate energy supply is among the most critical of factors to allow
functional recovery of the cardiomyocytes after the isolation process[14, 15]. We, like others,
have noticed that one major factor behind failed cell isolations is the duration of ischemia.
Most importantly, many heart disease models are extremely sensitive to ischemia, more so
than wild-type control hearts. The ATP consumption is increased significantly in some geneti-
cally-manipulated heart disease models[16–19], which may cause these hearts to be more vul-
nerable to ischemic injury than the healthy control. The ultimate challenge for some of our
experiments is to isolate cardiomyocytes that can perform well in conditions of repetitive exci-
tation-contraction under mechanical load. Typically this demands an even greater energy sup-
ply be available than load-free conditions.
Here we describe a new cell isolation method using in vivo cannulation of the carotid artery
or the aorta, in conjunction with cardiac arrest, to minimize myocardial ischemia. This fine-
tuned but easily reproducible protocol has enabled us to consistently obtain high-quality cardi-
omyocytes from murine wild-type and heart disease models, to a greater extent than other pro-
tocols our laboratory has used in the past. The purpose of this paper is to make available this
novel method for isolating high quality cardiomyocytes to a range of experimentalists. We
illustrate these concepts by measuring the ability of the single cardiomyocytes to perform
steady-state excitation, Ca2+ signaling, and mechanical contraction; to respond to beta-adren-
ergic stimulation, and to contract robustly under mechanical loads. This methodology should
be useful for many investigators.
Materials and Methods
Equipment
A Langendorff system for constant retrograde perfusion and pressure measurement of murine
hearts was set up as described previously[6]. The perfusate in the reservoir was pumped into
the heart via a cannula onto which the aorta or carotid artery was mounted. The temperature
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of the perfusate was maintained by pre-heating it in a water bath, and also by a heating coil
that wraps around the perfusion tubing. The temperature of the perfusate delivered from the
cannula was calibrated to 37°C by adjusting both the heating bath and the heating coil. A
3-way valve was interposed between the outlet of the heating coil and the vessel cannula, with a
pressure transducer (BLPR2, WPI) mounted on the third line, so that pressure changes dis-
played on a pressure monitor (SYS-BP1, WPI) could be monitored during the perfusion and
digestion procedure. A basic microsurgery platform was set up for in vivo cannulation and for
monitoring the heart tissue during enzyme digestion.
Solutions
All solutions were freshly made and sterile-filtered using a 0.22 μm filter, right before use. Prac-
tical instructions are detailed below for making the various solutions used in this protocol.
1. Perfusion solution base (in mmol/L) contained: NaCl 113, KCl 4.7, MgSO4 1.2, Na2HPO4
0.6, KH2PO4 0.6, NaHCO3 12, KHCO3 10, Taurine 30, Hepes 10 and glucose 5; pH = 7.4
(adjusted with NaOH) and Osmolality = 302 mOsm.
2. Cardioplegic solution was made by using 100 ml perfusion solution base and adding 1mg/ml
bovine serum albumin (BSA). This Ca2+ free and high K+ (15.3 mmol/L total K+ in perfusion
solution base) is used for arresting excitation-contraction.
3. Enzyme digestion solution was made by using 50 ml perfusion solution base to dissolve 300
u/ml Collagenase type II (Worthington Biochemicals, USA) and 0.04 mg/ml protease type
XIV (Sigma, USA), and then adding 12.5 μmol/L Ca2+. This enzyme solution can be recy-
cled if more digestion time is needed. Note that different batches of Collagenase may have
different enzyme activity (specified in the datasheet fromWorthington Biochemicals).
Hence the optimal enzyme concentration needs to be found by experimental testing. We
usually start with the above condition and then adjust the enzyme concentration to find the
optimal result empirically.
4. BCS solution was made by adding 3 ml bovine calf serum (BCS) into 27 ml perfusion solu-
tion base, and then adding Ca2+ 12.5 μmol/L.
5. Incubation solution base (in mmol/L) contained: NaCl 133.5, KCl 4.0, NaH2PO4 1.2, HEPES
10, MgSO4 1.2, and glucose 10; pH = 7.4 (adjusted with NaOH) and Osmolality = 298
mOsm.
6. Ca2+ ladder solutions were made by distributing 25 ml Incubation solution base into each of
three test tubes, and then adding 50 μl, 125 μl, and 250 μl of Ca2+ stock solution (100 mM)
into each tube to make solutions of 0.2 mmol/L, 0.5 mmol/L, and 1.0 mmol/L Ca2+ concen-
tration, respectively. The solutions were warmed to 37°C in a water bath.
Animal preparation
The use of animals in this study was reviewed and approved by the University of California,
Davis, Animal Use and Care Committee (IACUC), and conducted in accordance with the
guidelines of Animal Use and Care of the National Institutes of Health and the University of
California.
Mice (male, 12–18 week of age) were anesthetized using isoflurane with medical grade oxy-
gen. Initially 4% isoflurane was used in an induction chamber and then 1.2%–2% isoflurane
was delivered through a nosecone, to maintain deep anesthesia throughout the entire
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procedure. A toe pinch test was performed initially after induction to make sure deep anesthesia
was achieved, before performing any surgical procedure. After shaving the hair and disinfecting
the surgical area with 70% ethanol, a small skin incision was made at the left inguinal area to
expose the femoral artery, and then heparin (500 IU) was injected to prevent blood coagulation.
In vivo cannulation methods
Carotid artery cannulation (Fig 1A and 1B). Carotid cannulation was used (instead of
aortic cannulation described below) when cardiomyocytes were judged to be prone to damage
in some genetically-manipulated and heart disease models. In this case, the right common
Fig 1. In vivo cannulation methods. (A) Schematic diagram of in vivo cannulation via the common carotid artery or via the
aorta. (B) shows photos of the carotid artery cannulation with suture of the needle cannula in place. This allow simmediate
perfusion of the heart with cardioplegic solution. Illustration of how to clamp the right common carotid artery or descending
aorta in place is also shown. (C) shows photo of a simpler procedure used cannulate the aorta. This allows immediate
perfusion of the heart. The heart is then excised from the thoracic cavity while maintaining perfusion, hung up onto the
Langendorff system. Then the cell isolation procedure is started. (D) shows a representative profile of vessel pressure change
during the enzymatic digestion. The pressure usually experiences a transient increase at the beginning of enzymatic digestion.
We adjust the perfusion rate to keep pressure lower than 120 mmHg, to avoid aortic valve damage. After this transient
increase, the pressure gradually decreases as the enzyme digestion progresses. Continuous compensation of the perfusion
rate is used to keep the pressure at 70 mmHg for aortic cannulation, and 90 mmHg for carotid artery cannulation, until the
pump rate reaches up to 6 ml/min (arrow). Typically then the vessel pressure suddenly drops. This indicates the appropriate
time to terminate enzyme digestion (arrow).
doi:10.1371/journal.pone.0160605.g001
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carotid artery (CCA) was exposed through blunt dissection and a ventral midline neck incision.
The digastric, sternomastoid, and omohyoid muscles were retracted using metal hooks. A loose
knot (6–0, silk suture) was placed around the CCA. The left CCA was exposed the same way as
described above and isolated from the surrounding tissue. The distal end of the left CCA was
ligated before the bifurcation of the internal and external carotid arteries. A loose knot was
placed around the CCA to allow holding the cannulas for later use. A blood vessel clamp
(No.1, Fine Science Tools, Foster City, CA) was placed at the proximal end of the CCA and a
small hole was made in the CCA, close to the knot at the distal end of the ligation. A cannula
(30G bent blunt needle, 16mm length) with a plastic tube mounted at the tip (shown in Fig
1B) was connected to the Langendorff perfusion system and was held by a micromanipulator.
Then the plastic tip was inserted into the CCA and secured by tightening the knot of the suture.
The clamp was then removed and the pulse was checked (seen as a pulsation in the cannula
tubing) to confirm a successful cannulation. The heart was maintained in near normal physio-
logical conditions by perfusion of oxygen-rich perfusate during the above procedure.
Next, celiotomy was performed to expose the vena cava, and 0.1 ml of high concentration
KCl (0.5 M) solution was injected via inferior vena cava to quickly arrest the heartbeat, so that
ATP consumption could be reduced. Infusion of the cardioplegic solution was immediately
started to keep pressure at 80–95 mmHg for 3–5 minutes. Meanwhile, the thorax was opened
by sternotomy, the pericardium was removed, and an incision was made on the top of the right
atrium. The loose knot on the right CCA was tightened and the descending thoracic aorta was
clamped to limit the perfusion to the thoracic area.
Aorta cannulation (Fig 1C). For wild-type mice or strains judged to have less vulnerabil-
ity to ischemic damage, we simplified the cannulation procedure but still were able to maintain
high cell quality and yields. The procedures for anesthesia, surgical site preparation and hepa-
rin injection were the same as described above. After waiting 3 minutes for heparin distribu-
tion, celiotomy was performed to expose the vena cava. Then 0.1 ml of 0.5 M KCl solution was
injected to arrest the heartbeat. The thorax was opened by sternotomy and the aorta arch was
identified and isolated. A 22G metal cannula (Kent Scientific Co., Torrington, Connecticut,
USA) mounted on a 1ml syringe filled with Cardioplegic solution, was inserted into the aorta
and secured by 6–0 silk suture. After a small incision was made on the top of the right atrium,
the heart was reperfused by a syringe injection, to push out blood. Then the heart was excised
from the chest and linked to the Langendorff perfusion system. Infusion of the Cardioplegic
solution was immediately started at a 3 ml/min rate. Note that it is critical to avoid any air in
the perfusion system by starting the solution flow before linking the heart to the cannula in the
Langendorff system.
Enzyme digestion
The Cardioplegic solution perfusion rate was adjusted to achieve a stable pressure at 50–70
mmHg for aorta cannulation or 80–95 mmHg for carotid artery cannulation. After this pres-
sure was maintained for 3–5 minutes, the perfusate was switched to the enzymatic digestion
solution. While the heart was under enzymatic digestion on the Langendorff system with con-
stant perfusion rate, the vessel pressure during the digestion process usually displayed a charac-
teristic profile as shown in Fig 1D. Based on this, we developed a criterion for judging the
appropriate time to stop enzyme digestion.
As illustrated in Fig 1D, during the early phase of enzyme digestion the pressure showed a
transient increase. It was generally necessary to adjust the perfusion rate to keep the pressure
lower than 120 mmHg to avoid risking aortic valve damage. After the initial transient increase,
then the pressure was seen to gradually decrease as the enzyme digestion progressed. During
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this period, we continuously adjusted the perfusion rate to maintain the pressure at about 70
mmHg for aortic cannulation, and at about 90 mmHg for carotid artery cannulation. These
pressure levels were maintained until the pump rate reached 6 ml/minute. Eventually, the ves-
sel pressure gradually decreased. When the pressure dropped to 30 mmHg for aortic cannula-
tion or 50 mmHg for carotid artery cannulation, we terminated enzyme digestion.
Successful completion of enzyme digestion was determined empirically since the myocardial
tissue became soft to the touch and appeared flaccid and pale. In our experience, the duration
of enzymatic digestion varied for different animal strains and also for different batches of
enzyme. (Collagenase can have different activity levels, ranging from 215–305 u/mg.) For
example, the digestion times varied from 6.5–12 minutes for wild type C57Bl/J6 mouse hearts,
7–11 minutes formdx (dystrophin-null) hearts, and 12–15 minutes for the familial hypertro-
phic cardiomyopathy model FHC (cTnT-R92Q) and vinculin heterozygous knockout (vcl+/-).
We found that once a unique perfusion pressure profile was determined to indicate appropriate
enzymatic digestion of a particular strain, it would consistently produce high quality cardio-
myocytes from that strain.
In our experience, the aortic cannulationmethod produced improved cell quality compared
to the conventional method, for all murine heart models tested. This included C57BL/6 wild-
type and various transgenic mouse models including nNOS-/-, eNOS-/-, andmdx. However, the
carotid artery cannulationmethod is needed for isolating high quality cardiomyocytes from
FHC and vcl+/- models which are notoriously difficult with the traditional method.
Cell isolation and Ca2+ ladder
For the final part of the protocol, the heart is cut down from the cannula and transferred to a
35mm petri dish containing BCS solution. Use a pair of sharp, fine scissors to dissect the heart;
ventricular tissue was cut into 4–5 small sections which were then gently teased apart with
fine-tip forceps. The tissue was then gently triturated with a transfer pipette to release cells
from the tissue. For some transgenic and disease models known to have fragile cells, such as
FHC or vcl+/-, shaking trituration (20mins, 60rpm, Reciprocal shaking bath 2870, Thermo Sci-
entific, Waltham, Massachusetts, USA) was used instead of pipetting. The cell suspension was
filtered through a 250 μmmesh to separate cells from remaining tissue pieces. Then the ven-
tricular myocytes were suspended in BCS solution containing 12.5 μmol/L Ca2+.
Next, we use the Ca2+ ladder solutions to gradually increase the Ca2+ concentration towards
a physiological level. The cardiomyocytes were collected from CBS solution by allowing cells to
sink to the bottom, then removing the supernatant, and resuspending the cells in the Ca2+ lad-
der solutions in three steps, by successive addition of 0.2 mM Ca2+ (20 minutes), then 0.5 mM
Ca2+ (15 minutes), and finally 1.0 mM Ca2+ (15 minutes). The cells were then stored in the
solution with 1.0 mM Ca2+ at room temperature (18–22°C) for further use.
Fine-tuning of the protocol for various transgenic and heart disease
models
We have described a basic protocol for using in vivo cannulation to isolate high quality cardio-
myocytes. This is summarized in Table 1. The basic protocol can be fine-tuned to optimize the
conditions for different strains of mice. For example, we have found that the wild type C57Bl/
J6 (WT), eNOS-/- [20–22], nNOS-/-[23–25], mdx[26, 27], and mice subjected to transverse aortic
constriction (TAC)[28], can yield high quality cells by using aorta cannulation. However, in
our experience, cardiac myocytes obtained from models such as familial hypertrophic cardio-
myopathy model FHC (cTnT-R92Q) and vinculin heterozygous knockout (vcl+/-)[29–32] are
more fragile and reproducible successful isolation required the carotid artery cannulation
In Vivo Cannulation Methods for Cardiomyocytes Isolation from Heart Disease Models
PLOS ONE | DOI:10.1371/journal.pone.0160605 August 8, 2016 6 / 16
method, adding 12.5 μMCa2+ in enzyme digestion solution, and using shaking trituration to
gently separate cells from digested tissue. In our experience, such fine-tuning has been neces-
sary for isolating viable cells from models such as the FHC and vcl+/- hearts, where sarcolem-
mal or sarcomeric proteins may predispose the cells to damage during the isolation process.
This fine tuning was absolutely required for these types of models so that cells could be used
for functional study of their excitation-contraction capacities, particularly under mechanically
loaded condition.
Confocal imaging of Ca2+ transients and cell morphology
As described in our previous publication[33], freshly isolated myocytes were loaded with the
Ca2+ indicator dye Fluo-4/AM, and paced by the bipolar electrical field stimulation with short
(4 ms) depolarization pulses at 0.5Hz.The acquisition of fluorescence images used an Olympus
FluoView 1000 Confocal system (Center Valley, Pennsylvania, USA), in which an inverted
microscope with a water immersion fluorescence objective (UPlanSApo 60X, NA1.2) was used.
Fluo-4 AM was excited with a 488 nm laser beam (laser power set to 5%), and the emission was
filtered by a bandpass filter BA505-605.
Fura-2 measurement of whole cell Ca2+ transient
Fura-2 loading was done by incubating the cells with 2.5 μM Fura-2/AM and 0.75 μM Pluro-
nic-127 (in 20% DMSO) at room temperature for 30 minutes, followed by 45 minutes incuba-
tion. The dye loaded cells were perfused in Tyrode solution containing (in mM): 150 NaCl, 5.4
KCl, 1.2MgCl2, 1 CaCl2, 10 Glucose at pH 7.4 during the experiment. An IonOptix system
with a Hyperswitch (IonOptix Inc., USA) and a Olympus X71 inverted microscope with a
water immersion fluorescence objective UPlanSPao 40X, 1.15 NA (Olympus USA), were used
for fluorescence excitation (340 nm and 380 nm) and emission acquisition (510/40nm filter)
by photomultiplier tube (PMT).
Measurement of myocyte contraction
The images of contracting myocytes were recorded using a high speed camera (Myocam-S, 240
up to 1000 frame/s, IonOptix system). The sarcomere pattern along the longitudinal axis was
used to calculate the sarcomere length during myocyte contraction in real time, by using a Fast
Table 1. Basic protocol for cardiomyocyte isolation using in vivo cannulation.
Cardiomyocyte Isolation Protocol Step-by-Step Flow Chart Aorta Cannulation Carotid Artery Cannulation
Pre-sedation using isoflurane 5% + O2 in an induction chamber
p p
Anesthesia using isoflurane 1.2–2% + O2 via nose cone
p p
Heparin injection into the femoral artery 0.1 ml, 500 u 0.1 ml, 500 u
Arrest heart by injecting KCl solution via vena cava 0.1 ml, 0.5 M 0.1 ml, 0.5 M
In vivo cannulation aorta carotid artery
Infusion of cardioplegic solution, at 37°C
p p
Infusion of enzyme digestion solution, at 37°C
p p
Stop enzymatic digestion (determined by monitoring the pressure profile) 7–12 min 10–15 min
Dissect out the ventricular tissue
p p
Isolation of cardiomyocytes by trituration in petri dish pipetting shaking
Stop enzyme digestion by incubating cells in BCS solution 15 min 15 min
Progressive increase of Ca2+ using Ca2+ ladder solutions
p p
Store cells in incubation solution with 1 mM Ca2+, at 18–22°C
p p
doi:10.1371/journal.pone.0160605.t001
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Fourier Transform algorithm. The myocyte contraction was measured by the shortening of sar-
comere length.
Results
Using the in vivo cannulation methods, we have consistently obtained high yield and high quality
cardiomyocytes from both wild-type and heart disease models. Importantly, the in vivo carotid
artery cannulation method enabled us to obtain high quality ventricular myocytes from some
heart disease models, when this was difficult or impossible with conventional methods. The high
quality of cardiomyocytes has been verified by important structural and functional measures.
Morphology of cardiomyocytes
Fig 2A shows an example of wild-type ventricular myocytes isolated using the aortic cannula-
tion method. Fig 2B shows ventricular myocytes isolated from FHCmodel using the carotid
artery cannulation method, which exemplifies the high quality of cardiomyocytes isolated from
this most difficult model. In all cases, the ventricular myocytes typically showed about 90%
Fig 2. Cardiomyocytes yield, morphology, and t-tubule integrity. (A) and (B) show examples of the
ventricular myocytes freshly isolated from a wild-type (WT) C57Bl/J6 mouse heart and from a cardiomyopathy
model (FHC, cTnT-R92Q), respectively. The yield of live ventricular myocytes was about 85% for WT (Aa) and
60% for FHCmice (Ba) as judged by rod-shaped cells; the dead cells appear pop-corn like. The health ventricular
myocyte morphology shows rod-shaped cells with defined edges and clear striations showing the sarcomeres
(Ab, Bb; scale bar: 20 μm). Di-8ANEPPS fluorescence images show a well-structured T-tubule system (Ac, Bc
scale bar: 20 μm). The sarcomere length (SL) measured from the transmittal images and from the Di-8
fluorescence images (Ad, Bd; scale bar: 2 μm) show an average slack SL value of 1.8 μm.
doi:10.1371/journal.pone.0160605.g002
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rod-shaped, viable cells, versus only 10% appearing as “popcorn-shaped” dead cells. The mor-
phology of the ventricular myocytes showed clear striations, sharp edges, and a clean surface.
Di8-ANEPPS staining showed clear and registered t-tubule structure (Fig 2C and 2D). This
excellent preservation of cell morphology was maintained during the entire course of our
experiments, for approximately 6–8 hours after cell isolation.
Excitation, Ca2+ signaling, and Contraction
Fig 3A shows that the isolated cardiomyocytes can achieve robust steady-state contraction,
measured as sarcomere shortening, at 1, 3, and even 5 hours after cell isolation. Normally the
cells were used for experiments within 6–8 hours. Furthermore, we assessed the excitation-con-
traction characteristics of cardiomyocytes by monitoring the action potential, the Ca2+ signal,
and the mechanical contraction during pacing. Fig 3B shows the simultaneous recording of
these three signals. The high quality of the cells was demonstrated by their ability to reach
steady-state action potential, Ca2+ transient, and contraction during repetitive pacing (Fig
3Ba). Compared to wild-type cells (Fig 3Bb, WT), FHC cells showed prolonged action poten-
tial, slower Ca2+ transient, and slower contraction (Fig 3Bb, R92Q).
Responsiveness to beta-adrenergic stimulation
Preservation of cell-surface receptors is an important criterion for high quality cell isolation.
To assess this we evaluated the responsiveness of the cardiomyocytes to beta-adrenergic recep-
tor stimulation. Fig 4A shows that the FHC cells are responsive to isoproterenol (ISO). The
cells were also able to reach steady-state excitation-contraction under beta-adrenergic stimula-
tion. ISO increased the Ca2+ transient (Fig 4B and 4D) and the contraction of cells (Fig 4C
and 4E), demonstrating intact functional beta-adrenergic receptors and signaling pathways.
Similarly, the wild-type cardiomyocytes were able to respond to ISO and reach steady-state
excitation and contraction. These results demonstrate that the cell-surface beta-adrenergic
receptors are well preserved after cell isolation and enzymatic digestion, even in FHC cells that
are more vulnerable to the cell isolation procedure than other strains.
Cardiomyocytes contraction under mechanically loaded condition
In vivo, during each heartbeat cardiomyocytes contract undermechanically loaded condition.
However, most in vitro experiments are conducted using cells in load-free conditions that are
non-physiological. Recently we developed a Cell-in-Gel method (Fig 5A) to impose mechanical
load on single cardiomyocytes during contraction. This is necessary for studying the mechanical
stress effects and mechano-chemo-transduction in cardiomyocytes[33]. Mechanical loading puts
a higher requirement on the energy demand and the overall cell quality than load-free conditions.
Fig 5B demonstrates that the FHC cardiomyocytes were able to contract in this system under
mechanical load. The mechanical loading caused an increase of the systolic Ca2+ transient through
mechano-chemo-transduction (Fig 5C and 5E), and also a reduction of contraction amplitude
occurred due to increased afterload (Fig 5D and 5F). Similar results were obtained in wile-type
cardiomyocytes[33]. In our experience, the in vivo cannulation technique is critically important
for isolating high quality cardiomyocytes that can contract robustly under mechanical loads.
Discussion
We have developed a novel and adaptable method to isolate high-quality cardiac myocytes
from mouse heart disease models. The innovations of this method include: (1) Use of in vivo
cannulation to minimize transient hypoxia and ischemia; carotid artery cannulation is used for
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Fig 3. Functional study of the AP, [Ca2+]i and contraction of isolated cardiomyocytes. Functional studies of the
excitation-contraction coupling properties were performed onWT and FHC cardiomyocytes paced at 1.0 Hz, at body
temperature (37°C). (A) Long-termmonitoring of cell contraction. The cells showed robustness of sarcomere length and
fractional shortening up to at least 5 hours after isolation. (B) shows typical recordings of the action potential (Ba), the
[Ca2+]i measured using fura-2 fluorescence ratio (Bb), and the contraction measured by shortening of the sarcomere
length (Bc). All three signals reach steady state, indicating the high quality of cells. FHC showed a longer APD, slower
Ca2+ transient and slower contraction than the wild-type.
doi:10.1371/journal.pone.0160605.g003
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transgenic and heart disease models that seem to be “fragile” as compared to aortic cannulation
for healthier models. (2) Arrest of heartbeat by injecting KCl solution via the inferior vena cava
prior to thoracotomy in order to reduce energy demands and contraction-related injury. (3)
Exclusion of butanedione monoxime (BDM) to avoid side effects on myocytes function. (4)
Development of standard criterion using the vessel pressure profile during enzyme perfusion,
to allow real-time monitoring of the tissue digestion stage, and to determine the optimal time
to terminate enzyme digestion. We have combined these innovations into an in vivo cannula-
tion protocol that can be fine-tuned to achieve consistent high-quality cardiomyocytes isola-
tion from mouse hearts of various transgenic and heart disease models.
Isolated single cardiomyocytes have been used in a wide range of experiments for studying
heart diseases, especially as most studies pursue the cellular and molecular mechanisms
Fig 4. Response to beta-adrenergic stimulation of cardiomyocytes from R92Q. The responsiveness of
cardiomyocytes to beta-adrenergic stimulation was tested using 30 nM isopreterenol (ISO). The myocytes
were paced at 0.5 Hz at room temperature (21°C). The Ca2+ signal and cell contraction were recorded using
Fluo-4 fluorescence confocal microscopy (A). Cardiomyocytes contracting in normal Tyrode solution were
defined as the load-free condition. Confocal linescan images show ISO treatment markedly increased the
Ca2+ transient measured by Fluo-4 fluorescence F/F0 ratio (B, D, n = 7 for control and ISO applied group).
and enhanced the load-free contraction measured as fractional shortening (C, E, n = 7 for both groups).
Unpaired Student’s t test; *P < 0.05, ***P < 0.001.
doi:10.1371/journal.pone.0160605.g004
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underlying the disease process. Many studies require evaluation of isolated live cells that retain
function as close to that present when they were in the intact heart. Such mechanistic studies
frequently cannot be done at the tissue and organ levels. In particular, functional studies of the
excitation-contraction coupling and evaluation of various signaling pathways during cardio-
myocyte contraction require high-quality live cells that have preserved all the molecular
machinery. Our in vivo cannulation method was indeed developed to meet the stringent
requirements for studying live cardiomyocyte functions (i.e. electrical excitation, signaling,
contraction under mechanically loaded condition, etc.). In comparison, when we tried using
more conventional cell isolation methods with BDM, we found that normal cardiomyocyte
excitation-contraction was impaired. BDM was also found to have irreversible effects on cardi-
omyocytes by other labs[3, 10–13]. Therefore we first opted to avoid use of BDM. But when we
tried using the conventional methods without BDM, cell isolation was difficult even for less
Fig 5. Mechanically loaded contraction andmechano-chemo-transduction of cardiomyocytes from R92Q.
(A) We used our Cell-in-Gel system [33] to impose a mechanical load during cardiomyocyte contraction. (B) Fluo-
4 confocal linescan images show Ca2+ signals during systole and diastole. Cell contraction was seen in the edge
shortening. The cells were able to reach steady-state contraction. Cardiomyocytes contracting in normal Tyrode
solution were defined as the load-free control. (C) Systolic Ca2+ transient (CaT) peak in cell-in-gel (n = 15) vs load-
free control (n = 19). (D) Fractional shortening of cardiomyocyte contraction in-gel (n = 15 cells) vs load-free
control (n = 18). (E) Mechano-chemo-transduction was seen in the significant enhancement of the Ca2+ transient
under load (n = 15), compared with load-free group (n = 19). (F) Meanwhile, the fractional shortening was
significantly decreased under mechanical load (n = 15), compared with load-free group (n = 18). Unpaired
Student’s t test; *P < 0.05, ***P < 0.001.
doi:10.1371/journal.pone.0160605.g005
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fragile hearts, and failed almost completely for “fragile” heart disease models. Cell yields were
very low (Fig 6), and the few survivors showed smaller Ca2+ transient, weaker contraction and
lack of responsiveness to beta-adrenergic stimulation. The cells died shortly later and could not
be used for further studies.
Because the quality of experimental data critically depends on the cell quality, we made sig-
nificant efforts to develop the in vivo cannulation method reported here. We also carried out
experimental studies to verify preservation of the function of the cardiomyocytes isolated with
this new methodology. Importantly, our recently developed Cell-in-Gel technique enabled us
to study single cardiomyocyte contraction in a 3-D viscoelastic gel matrix (extracellular matrix
surrogate) environment, under mechanically loaded condition (Fig 5). Many previous single
cell experiments were performed under less stringent, load-free conditions. In comparison,
mechanically loaded contraction puts much higher demands on the cell integrity and
Fig 6. Comparing the cells isolated using traditional method and the in-vivo cannulation method. (A)
and (B) show the significant difference of isolation quality of the ventricular myocytes from a cardiomyopathy
model (FHC, cTnT-R92Q). The ventricular myocytes were freshly isolated using traditional methods versus
using our in vivo cannulation method. The butanedione monoxime (BDM) was excluded from solution recipes
because of its significant side effects on the cardiomyocytes. The yield of live ventricular myocytes was
normally less than 30% for traditional method (Aa) and larger than 60% for in vivo method (Ba) as judged by
rod-shaped cells; the dead cells appear pop-corn like. The healthy ventricular myocyte morphology shows
rod-shaped cells with defined edges and clear striations showing the sarcomeres. Compared with cells by in
vivo cannulation method, the ventricular myocytes isolated by conventional way showed a smaller Ca2+
transient (Ab n = 29 vs Bb n = 19), weaker contraction (Ac n = 24 vs Bc n = 18) and lack of responsiveness to
beta-adrenergic stimulation (n = 5 using traditional method vs n = 7 using in-vivo cannulation method).
Unpaired Student’s t test; *P < 0.05, ***P < 0.001.
doi:10.1371/journal.pone.0160605.g006
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energetics than load-free conditions. In our experience, the in vivo cannulation method has
been able to consistently produce high quality cardiomyocytes from various mouse heart dis-
ease models. This allowed us to meet the new challenges and opportunities of studying single
cardiomyocyte function under various mechanical loads mimicking in vivo conditions. We
think that the new method reported here will help researchers to isolate higher yields and better
quality cardiomyocytes from all types of model systems.
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